Literature DB >> 9643289

A survey of phenotypic features in juvenile polyposis.

D C Desai1, V Murday, R K Phillips, K F Neale, P Milla, S V Hodgson.   

Abstract

Solitary juvenile polyps are quite frequent in children, but juvenile polyposis (JP) is a rare autosomal dominant trait characterised by the occurrence of numerous polyps in the gastrointestinal tract. Extracolonic phenotypic abnormalities are well documented in patients with familial adenomatous polyposis and Peutz-Jeghers syndrome and can allow a clinical diagnosis to be made before the bowel pathology becomes available. Though described, characteristic extracolonic abnormalities have not been clearly defined in juvenile polyposis. We sought to determine whether there are consistent extracolonic phenotypic abnormalities in JP patients and how frequently this would allow diagnosis of one of the genetic syndromes known to be associated with juvenile polyposis. Twenty-two JP patients underwent clinical examination and data from one patient were obtained from case notes. Those consenting to further investigations had x rays of the skull, chest, and hands and an echocardiogram if clinically indicated. Significant extracolonic phenotypic abnormalities were present in 18 patients (14 male and four female), and included dermatological (13), skeletal (16), neurological (5), cardiopulmonary (4), gastrointestinal (3), genitourinary (4), and ocular (1) features. In five patients the diagnosis of a genetic syndrome was possible: two had Bannayan-Riley-Ruvalcaba syndrome, two had Gorlin syndrome, and one had hereditary haemorrhagic telangiectasia (HHT, also known as Osler-Rendu-Weber syndrome). Other patients had some features of these conditions and of Cowden and Simpson-Golabi-Behmel syndromes, but these were not sufficient to allow a definitive diagnosis.

Entities:  

Mesh:

Year:  1998        PMID: 9643289      PMCID: PMC1051342          DOI: 10.1136/jmg.35.6.476

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  29 in total

Review 1.  Polyposis syndromes--an update.

Authors:  N A Shepherd; H J Bussey
Journal:  Curr Top Pathol       Date:  1990

2.  Bannayan-Riley-Ruvalcaba syndrome.

Authors:  R J Gorlin; M M Cohen; L M Condon; B A Burke
Journal:  Am J Med Genet       Date:  1992-10-01

Review 3.  [The syndrome of juvenile polyposis].

Authors:  I Höfting; G Pott; M Stolte
Journal:  Leber Magen Darm       Date:  1993-05

4.  Exclusion of APC and MCC as the gene defect in one family with familial juvenile polyposis.

Authors:  B A Leggett; L R Thomas; N Knight; S Healey; G Chenevix-Trench; J Searle
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

5.  Colorectal neoplasia in juvenile polyposis or juvenile polyps.

Authors:  F M Giardiello; S R Hamilton; S E Kern; G J Offerhaus; P A Green; P Celano; A J Krush; S V Booker
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

6.  Further localization of the gene for nevoid basal cell carcinoma syndrome (NBCCS) in 15 Australasian families: linkage and loss of heterozygosity.

Authors:  G Chenevix-Trench; C Wicking; J Berkman; H Sharpe; A Hockey; E Haan; C Oley; D Ravine; A Turner; D Goldgar
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

7.  Familial juvenile polyposis coli; increased risk of colorectal cancer.

Authors:  H Järvinen; K O Franssila
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

8.  Basal cell carcinoma in a patient with intestinal polyposis.

Authors:  V V Michels; J C Stevens
Journal:  Clin Genet       Date:  1982-08       Impact factor: 4.438

9.  Location of gene for Gorlin syndrome.

Authors:  P A Farndon; R G Del Mastro; D G Evans; M W Kilpatrick
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

10.  Ruvalcaba-Myhre-Smith syndrome: a new consideration in the differential diagnosis of intestinal polyposis.

Authors:  M A Foster; R F Kilcoyne
Journal:  Gastrointest Radiol       Date:  1986
View more
  9 in total

1.  Mutation screening in juvenile polyposis syndrome.

Authors:  Robert E Pyatt; Robert Pilarski; Thomas W Prior
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

2.  [Colorectal polyposis syndrome: a guide to diagnosis].

Authors:  A Roessner; D Kuester; T Guenther
Journal:  Pathologe       Date:  2011-07       Impact factor: 1.011

3.  Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood.

Authors:  Michael Manfredi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-03

Review 4.  Malignant tumors associated with juvenile polyposis syndrome in Japan.

Authors:  Hideyuki Ishida; Keiichiro Ishibashi; Takeo Iwama
Journal:  Surg Today       Date:  2017-05-26       Impact factor: 2.549

5.  High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome.

Authors:  S Aretz; D Stienen; S Uhlhaas; M Stolte; M M Entius; S Loff; W Back; A Kaufmann; K-M Keller; S H Blaas; R Siebert; S Vogt; S Spranger; E Holinski-Feder; L Sunde; P Propping; W Friedl
Journal:  J Med Genet       Date:  2007-09-14       Impact factor: 6.318

6.  An audit of familial juvenile polyposis at the Tel Aviv Medical Center: demographic, genetic and clinical features.

Authors:  Paul Rozen; Ziona Samuel; Eli Brazowski; Markus Jakubowicz; Jacob Rattan; Zamir Halpern
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

7.  Matrix metalloproteinases in the urine and tissue of patients with juvenile polyps: potential biomarkers for the presence of polyps.

Authors:  Michael A Manfredi; Victor L Fox; David Zurakowski; Jeffery L Kutok; Jonathan N Glickman; Marsha A Moses
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-04       Impact factor: 2.839

8.  Hereditary hemorrhagic telangiectasia in association with generalised juvenile polyposis.

Authors:  J S Gillespie; R A McIvor
Journal:  Ulster Med J       Date:  2001-11

9.  Juvenile polyposis syndrome.

Authors:  Wojciech Cichy; Beata Klincewicz; Andrzej Plawski
Journal:  Arch Med Sci       Date:  2014-06-27       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.